Scientists at the Medical Research Council’s Laboratory of Molecular Biology in Cambridge say new understanding about how to control autoimmune responses offers promise in efforts to develop treatments for rheumatoid arthritis (RA), British researchers say.
RA — a painful, inflammatory form of arthritis — occurs when the body’s immune system attacks itself. A molecule called Foxp3 […]
continue reading from " New Therapy Could Transform Arthritis Treatment "
